Three Measures for the Prevention of Carious Lesions in Preschool Children

Sponsor
Zhejiang University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02341352
Collaborator
Hangzhou Occupational Disease Prevention Hospital (Other)
500
1
4
26
19.2

Study Details

Study Description

Brief Summary

Analysis different measures preventive effect on carious Lesions incidence and oral microecological system change of preschool children

Condition or Disease Intervention/Treatment Phase
  • Drug: fluoride varnish
  • Biological: Immunoglobulin Yolk
  • Dietary Supplement: Probiotics
Phase 3

Detailed Description

Different caries prevention trials including fluoride vanish, IgY-passive immunotherapy and probiotics lasting 24 months were conducted with a total of 500 children aged 24 to 54 months of age in Lin'an, Zhejiang, China. The trials were cluster- domized .After obtaining parent´s informed consent, preschool children were clinical examinated according to ICDAS-Ⅱ and microbiological tested of saliva at baseline, 1m, 6m, 12m, 18m and 24m. To find the differences of caries incidence and oral microecology change in four groups, dmfs will be assessed and saliva will be analysed in experiment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
500 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Study on Children's Dental Caries Prevention and Mechanism
Study Start Date :
Apr 1, 2013
Anticipated Primary Completion Date :
Apr 1, 2015
Anticipated Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Only behavioral education for Caregiver

Experimental: fluoride varnish

fluoride varnish every 6 months

Drug: fluoride varnish
Sodium fluoride 50mg/ml
Other Names:
  • Duraphat(Colgate-palmolive company)
  • Experimental: ImmunoglobulinY

    anti-S.mutans Immunoglobulin yolk for everyday use

    Biological: Immunoglobulin Yolk
    anti-Streptococcus mutans IgY
    Other Names:
  • Aoliding oral bacteriostatic spray(Hangzhou YaSheng Biotech)
  • Experimental: Probiotics

    Probiotics use for 1 months

    Dietary Supplement: Probiotics
    2g/day,Lactobacillus rhamnosus HN001, Bifidobacterium lactis Bi-07, Bifidobacterium lactis HN019, maltodextrin, fructose, skimmed milk powder
    Other Names:
  • Probiotics milk power(Minsheng Pharmaceutical)
  • Outcome Measures

    Primary Outcome Measures

    1. The number of new cavitated or incipient carious lesion [24 months after first visit]

      To determine whether preschool children that only with caregiver behavior education have more new caries lesion than those taken some caries preventive measures by differences in dmfs(decay,missing,filling teeth surfaces) index after 24 months dental exams.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    24 Months to 54 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • preschool children in good general health

    • At least 18 deciduous teeth

    Exclusion Criteria:
    • With major systemic disease or on long-term medication

    • Not cooperative and refuse dental treatment

    • With a history of extra fluoride supplement

    • Take antibiotics for nearly 8 weeks

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Affiliated Hospital of Stomatology, School of Medicine, Zhejiang University Hangzhou Zhejiang China 310006

    Sponsors and Collaborators

    • Zhejiang University
    • Hangzhou Occupational Disease Prevention Hospital

    Investigators

    • Principal Investigator: Hui Chen, Department of Conservative Dentistry and Periodontics, Affiliated Hospital of Stomatology, School of Medicine, Zhejiang University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Xi Chen, Master, Zhejiang University
    ClinicalTrials.gov Identifier:
    NCT02341352
    Other Study ID Numbers:
    • 2013-8
    • 81371142
    • 20120633B14
    First Posted:
    Jan 19, 2015
    Last Update Posted:
    Jan 19, 2015
    Last Verified:
    Jan 1, 2015

    Study Results

    No Results Posted as of Jan 19, 2015